Therapeutic Strategies in Metastatic Colorectal Cancer

Therapeutic Strategies in Metastatic Colorectal Cancer

Episodes

Specialty:

All

Year:

All

EP. 1: Taking a Multidisciplinary Approach to mCRC Care

February 12th 2016

EP. 2: Metastatic Colorectal Cancer: Goals of Resection

February 12th 2016

EP. 3: Liver-Directed Therapies in Metastatic Colorectal Cancer

February 12th 2016

EP. 4: Molecular Profiling in Colorectal Cancer

February 12th 2016

EP. 5: Immunotherapy and MSI Status in Colorectal Cancer

February 12th 2016

EP. 6: Systemic Therapy Approaches in mCRC

February 12th 2016

EP. 7: FOLFOX versus FOLFIRI in the MAVERICC Trial in CRC

February 12th 2016

EP. 8: Optimizing Frontline Chemotherapy in mCRC

February 12th 2016

EP. 9: Considering Maintenance Therapy in mCRC

February 12th 2016

EP. 10: Second-Line Therapy Options in mCRC

February 12th 2016

EP. 11: Regorafenib in Advanced Colorectal Cancer: Dosing Strategies

February 12th 2016

EP. 12: The Role of TAS-102 in Metastatic Colorectal Cancer

February 12th 2016

EP. 13: Sequencing Decisions in Relapsed/Refractory Colorectal Cancer

February 12th 2016

Trending on OncLive

Updated NCCN Guidelines Feature Additional MRD Recommendations in Multiple Myeloma

CHMP Recommends Label Expansion of Melflufen to Third-Line Lenalidomide-Refractory Multiple Myeloma

Phase 1 Data Support DAWN-303’s Evaluation of INCB161734 in Frontline KRAS G12D–Mutated PDAC

Mosunetuzumab Plus Lenalidomide Improves PFS in R/R Follicular Lymphoma

Episode 2: Taking Stock of Systemic and Local Therapy Trends in Lung Cancer With Drs Crowley and Moghanaki